Pediatric adrenocortical carcinoma.
Ilanchezhian M, Varghese DG, Glod JW, Reilly KM, Widemann BC, Pommier Y, Kaplan RN, Del Rivero J.
Front Endocrinol (Lausanne). 2022 Oct 31;13:961650. doi: 10.3389/fendo.2022.961650. eCollection 2022.
Adrenocortical endocrine disruption.
Harvey PW.
J Steroid Biochem Mol Biol. 2016 Jan;155(Pt B):199-206. doi: 10.1016/j.jsbmb.2014.10.009. Epub 2014 Oct 18.
Myxoid adrenocortical adenoma.
Lai B, He Z, Luo T, Huang Y.
Asian J Surg. 2023 Apr;46(4):1813-1814. doi: 10.1016/j.asjsur.2022.10.043. Epub 2022 Oct 27.
Adrenocortical Carcinoma with Hypercortisolism.
Puglisi S, Perotti P, Pia A, Reimondo G, Terzolo M.
Endocrinol Metab Clin North Am. 2018 Jun;47(2):395-407. doi: 10.1016/j.ecl.2018.02.003. Epub 2018 Apr 9.
Treatment of Adrenocortical Carcinoma.
Vaidya A, Nehs M, Kilbridge K.
Surg Pathol Clin. 2019 Dec;12(4):997-1006. doi: 10.1016/j.path.2019.08.010. Epub 2019 Sep 27.
Advances in translational research of the rare cancer type adrenocortical carcinoma.
Ghosh C, Hu J, Kebebew E.
Nat Rev Cancer. 2023 Dec;23(12):805-824. doi: 10.1038/s41568-023-00623-0. Epub 2023 Oct 19.
Adrenocortical carcinoma: review and update.
Erickson LA, Rivera M, Zhang J.
Adv Anat Pathol. 2014 May;21(3):151-9. doi: 10.1097/PAP.0000000000000019.
A Diagnostic Approach to Adrenocortical Tumors.
Hodgson A, Pakbaz S, Mete O.
Surg Pathol Clin. 2019 Dec;12(4):967-995. doi: 10.1016/j.path.2019.08.005. Epub 2019 Sep 27.
Adrenocortical carcinoma, case report.
Cortés-Vázquez YD, Mejía-Rios LC, Priego-Niño A, Salgado-Arroyo V, Cabrales-Santiago HE, Gutiérrez-Quiróz C, Cruz NO.
Cir Cir. 2021;89(5):664-668. doi: 10.24875/CIRU.20000693.
Adrenocortical carcinoma.
van Ditzhuijsen CI, van de Weijer R, Haak HR.
Neth J Med. 2007 Feb;65(2):55-60.
